- BETA DRUGS LIMITED
BETA DRUGS LIMITED Share Price
NSE: BETA
Pharmaceuticals
₹1,774.00
+₹11.80 (0.67%) Last updated on 20 Jun, 2025 | 15:20 ISTBETA DRUGS LIMITED Overview
Market cap  ₹1,791 Crs | Open ₹1,762.20 | Prev. Close ₹1,762.20 |
Circuit range ₹2,128.80 - ₹1,419.20 | Day range ₹1,762.20 - ₹1,795.00 | Year range ₹1,121.95 - ₹2,215.30 |
Volume 3,255 | Avg. traded ₹1,777.30 | Revenue (12m) ₹362 Crs |
About BETA DRUGS LIMITED
Beta Drugs Limited is an India-based oncology medicine manufacturing company. The Company specializes in the intricate field of complex chemical synthesis for anti-cancer bulk drugs and finished dosages. The Company operates through one segment, Pharmaceuticals. Its product category includes cosmeceutical products and oncology products. The cosmeceutical products include La’Thrix, BACINOX, URTICALM, HUMIDA, NUSPLASH, UVIREX, ADVIBE, SENSIBAR, and RECAPRO. The oncology products include Temozad(Temozolomide), ADVIN(Vinorelbine), ADSIDE(Etoposide), ADRIB(Doxorubicin), ADCOV(Leucovorin calcium), ADCOV(Leucovorin calcium), ADPLATIN(Oxaliplatin), INOTAD(Irinotecan), ADCIST(Cisplatin), ADCARB(Carboplatin), ERLOTAD(Erlotinib), ADOXI(Docetaxel), AMGICIN(Gemcitabine), ADPAXIL(Paclitaxel), ADMIDE(Bicalutamide), and others. The Company's subsidiaries include Adley Lab Limited and Adley Formulations Private Limited.
BETA DRUGS LIMITED Share Price Chart
Please wait...
BETA DRUGS LIMITED Key Indicators
P/E ratio 41.04 | P/B ratio 9.37 | ROE 20.67% |
ROCE 27.27% | Dividend yield -- | Debt/Equity ratio 0.05 |
EPS 22.82 |
Investment Checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
BETA DRUGS LIMITED Financial Ratios
Operating profit margin17.84% | Net profit margin11.1% |
ROE20.67% | ROA14.06% |
ROCE27.27% |
Quick ratio1.92 | Current ratio2.24 |
Interest coverage29.15 | Asset turnover1.27 |
Debt to Equity0.05 |
P/E ratio41.04 | P/B ratio9.37 |
EV / EBITDA33.03 | |
Dividend yield0% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-24 | ₹295.71 | ₹61.36 | ₹36.44 |
Mar-23 | ₹227.11 | ₹53.88 | ₹30.72 |
Mar-22 | ₹183.84 | ₹43.45 | ₹24.83 |
Mar-21 | ₹116.12 | ₹25.24 | ₹11.72 |
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-24 | ₹-13.97 | ₹-7.49 | |
Mar-23 | ₹-19.07 | ₹-2.47 | |
Mar-22 | ₹-21.75 | ₹-0.97 | |
Mar-21 | ₹-5.85 | ₹-7.71 |
Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-24 | ₹262.42 | ₹105.30 |
Mar-23 | ₹203.91 | ₹81.03 |
Mar-22 | ₹163.05 | ₹70.71 |
Mar-21 | ₹120.15 | ₹51.53 |
BETA DRUGS LIMITED Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jun-25 | ₹1,762.20 | ₹1,774.00 | |
19-Jun-25 | ₹1,787.55 | ₹1,762.20 | -1.42% |
18-Jun-25 | ₹1,774.00 | ₹1,787.55 | -0.05% |
17-Jun-25 | ₹1,824.00 | ₹1,788.50 | -0.80% |
16-Jun-25 | ₹1,805.00 | ₹1,803.00 | -0.39% |
13-Jun-25 | ₹1,755.00 | ₹1,810.00 | |
12-Jun-25 | ₹1,809.00 | ₹1,793.25 | -0.25% |
11-Jun-25 | ₹1,828.50 | ₹1,797.70 | -1.14% |
Corporate Actions
Bonus • 1:20
Ex date 26 Mar 2025
Stocks Similar to BETA DRUGS LIMITED
Stock Name | Price | Change % |
|---|---|---|
| ANG LIFESCIENCES INDIA LIMITED | ₹28.56 | -₹0.58 (-1.99%) |
| ANUH PHARMA LIMITED | ₹206.54 | -₹1.24 (-0.6%) |
| Ind Swift Laboratories | ₹106.50 | +₹5.01 (4.94%) |
| Lincoln Pharma | ₹565.00 | +₹0.55 (0.10%) |
| Lyka Labs | ₹113.01 | +₹0.78 (0.70%) |
| Nectar Lifesciences | ₹21.40 | +₹0.57 (2.74%) |
| VENUS REMEDIES | ₹431.00 | +₹5.20 (1.22%) |
| Windlas Biotech | ₹884.40 | +₹5.45 (0.62%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| AVP INFRACON LIMITED | ₹185.00 | +₹6.70 (3.76%) |
| CDSL | ₹1,685.80 | +₹48.00 (2.93%) |
| HDFC Bank | ₹1,964.70 | +₹29.40 (1.52%) |
| JIO FIN SERVICES LTD | ₹294.25 | +₹10.15 (3.57%) |
| Newgen Software Tech | ₹1,153.40 | -₹38.40 (-3.22%) |
| Reliance | ₹1,466.20 | +₹32.90 (2.30%) |
| Shakti Pumps (India) | ₹964.95 | +₹10.70 (1.12%) |
| Tata Motors | ₹676.20 | +₹3.90 (0.58%) |
| Varun Beverages | ₹459.60 | +₹10.95 (2.44%) |
| ZAGGLE PREPA OCEAN SER L | ₹402.60 | -₹2.90 (-0.72%) |
BETA DRUGS LIMITED News
FAQs on BETA DRUGS LIMITED
What is the share price of BETA DRUGS LIMITED today?
BETA DRUGS LIMITED share price is ₹ 1,774.00 as on 20 Jun, 2025 | 15:20 IST.
What are the high & low stock price of BETA DRUGS LIMITED today?
BETA DRUGS LIMITED stock price hit a high of ₹ 1,795.00 and low of ₹ 1,762.20 as on 20 Jun, 2025 | 15:20 IST.
What is the market cap of BETA DRUGS LIMITED?
The market cap of BETA DRUGS LIMITED is ₹ 1,790.77 Crores as on 20 Jun, 2025 | 15:20 IST.
What are the the 52-week high and low share prices of BETA DRUGS LIMITED stock on the NSE?
52-week high stock Price of BETA DRUGS LIMITED is ₹ 2,215.30 and Low Price is ₹ 1,121.95 as on 20 Jun, 2025 | 15:20 IST.
What are the stock symbols of BETA DRUGS LIMITED?
The stock symbol of BETA DRUGS LIMITED is NSE: BETA on the NSE, , and the ISIN is INE351Y01019.
Can I buy BETA DRUGS LIMITED shares on Holidays?
No, shares of BETA DRUGS LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell BETA DRUGS LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of BETA DRUGS LIMITED?
The PE and PB ratio of BETA DRUGS LIMITED is 41.04 and 9.37 respectively, as on 20 Jun, 2025 | 15:20 IST.
What are the returns on BETA DRUGS LIMITED shares?
The historical returns for BETA DRUGS LIMITED shares are 55.17 for 1 year, 181.1 for 3 year and 2928.85 for 5 year.